tradingkey.logo

Corbus Pharmaceuticals Holdings Inc <CRBP.OQ> expected to post a loss of $1.28 a share - Earnings Preview

ReutersMay 2, 2025 1:33 PM
  • Corbus Pharmaceuticals Holdings Inc CRBP.OQ CRBP.O is expected to show no change in quarterly revenue when it reports results on May 5 (estimated) for the period ending March 31 2025

  • ​LSEG's mean analyst estimate for Corbus Pharmaceuticals Holdings Inc is for a loss of $1.28 per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts had fallen by about 0.5% in the last three months. ​

  • Wall Street's median 12-month price target for Corbus Pharmaceuticals Holdings Inc is $51.00​, above​ its last closing price of $7.52. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-1.26

-1.27

-0.78

Beat

38.4

Sep. 30 2024

-0.95

-0.95

-1.15

Missed

-20.8

Jun. 30 2024

-1.16

-1.19

-0.90

Beat

24.2​

Mar. 31 2024

-1.09

-1.09

-0.83

Beat

23.9

​​Dec. 31 2023

-2.22

-2.36

-1.81

Beat

23.3

Sep. 30 2023

-2.06

-2.06

-2.05

Beat

0.5​

Jun. 30 2023

-3.10

-3.10

-2.05

Beat

33.9

Mar. 31 2023

-4.09

-4.09

-4.24

Missed

-3.7

This summary was machine generated May 2 at 13:33 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI